EGF and prostate carcinoma: In all prostate cancer cell lines, the cytotoxic effect of EGF-PE24mut-ΔREDLK was not only reconstituted, but also multiplied by endosomal escape enhancement, despite its at least 11-fold lower intrinsic toxicity compared to EGF-PE24mut.